Xias Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$4.76M
- Investors
-
6
Xias Bio General Information
Description
Operator of engineered protein technology intended to replace animal-derived proteins with sustainable bioengineered alternatives. The company offers fermentation-based multifunctional proteins, modular protein engineering platforms, and customizable peptide development capabilities, enabling cosmetics, personal care, biotechnology, and industrial manufacturers to improve ingredient performance with scalable and environmentally responsible materials.
Contact Information
Website
www.xiasbio.comCorporate Office
- E116, UWS Paisley Campus, Lady Lane
- Paisley PA1 2BE
- Scotland, United Kingdom
Corporate Office
- E116, UWS Paisley Campus, Lady Lane
- Paisley PA1 2BE
- Scotland, United Kingdom
Xias Bio Timeline
Xias Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 01-May-2024 | $4.76M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 25-Aug-2023 | Completed | Generating Revenue | |||
| 1. Angel (individual) | 02-Sep-2021 | $68.9K | $68.9K | Completed | Generating Revenue |
Xias Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred Shares | ||||||||
| Preferred Shares | ||||||||
| Preferred Shares | ||||||||
| Ordinary | 2,104 | $1.250852 | $47.58 | $47.58 | 1x | $47.58 | 2.82% | |
| Ordinary | 4,088 | $1.250852 | $15.3 | $15.3 | 1x | $15.3 | 5.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Xias Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Xias Bio Patents
Xias Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202502443-D0 | Peptides | Pending | 19-Feb-2025 | ||
| GB-2704756-A | Peptides | Pending | 19-Feb-2025 | ||
| WO-2026176181-A1 | Peptides | Pending | 19-Feb-2025 | ||
| GB-2639537-A | Peptides | Pending | 19-Feb-2024 | ||
| WO-2025176987-A1 | Peptides | Pending | 19-Feb-2024 | C07K14/43518 |
Xias Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Xias Bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BoxOne Ventures | Venture Capital | Minority | ||
| CPT Capital | Venture Capital | Minority | ||
| Good Startup | Venture Capital | Minority | ||
| Happiness Capital | Corporate Venture Capital | Minority | ||
| IndieBio | Accelerator/Incubator | Minority |
Xias Bio FAQs
-
When was Xias Bio founded?
Xias Bio was founded in 2020.
-
Where is Xias Bio headquartered?
Xias Bio is headquartered in Paisley, United Kingdom.
-
What is the size of Xias Bio?
Xias Bio has 11 total employees.
-
What industry is Xias Bio in?
Xias Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Xias Bio a private or public company?
Xias Bio is a Private company.
-
What is the current valuation of Xias Bio?
The current valuation of Xias Bio is .
-
What is Xias Bio’s current revenue?
The current revenue for Xias Bio is .
-
How much funding has Xias Bio raised over time?
Xias Bio has raised $5.36M.
-
Who are Xias Bio’s investors?
BoxOne Ventures, CPT Capital, Good Startup, Happiness Capital, and IndieBio are 5 of 6 investors who have invested in Xias Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
